Similar observations were made in Ph+ ALL, where BCL6 expression was upregulated following TKI treatment, resulting in the repression of CDKN1A, CDKN1B, and TP53 (Duy et al., 2011). Here, BCL6 is linked to acute lymphoblastic leukemia.